Publications (52) Gregorio Castellanos Escrig publications

2024

  1. Clinical outcomes after discontinuing anticoagulant therapy in patients with first unprovoked venous thromboembolism

    Journal of Thrombosis and Haemostasis, Vol. 22, Núm. 8, pp. 2234-2246

  2. Rate of recurrence after discontinuing anticoagulation in patients with venous thromboembolism within 30 days after COVID-19 vaccine

    European Journal of Clinical Investigation

  3. The prognostic value of blood cellular indices in pulmonary embolism

    American Journal of Hematology, Vol. 99, Núm. 9, pp. 1704-1711

  4. Venous Thromboembolism after Hospital Discharge: Temporal Trends in Baseline Characteristics, Prevention, Treatment, and 90-day Outcomes

    Seminars in Thrombosis and Hemostasis

  5. Venous thromboembolism characteristics and outcomes among RIETE patients tested and untested for inherited thrombophilia

    Blood Advances, Vol. 8, Núm. 18, pp. 4950-4959

2023

  1. Amniotic Membrane Restores Chronic Wound Features to Normal in a Keratinocyte TGF-β-Chronified Cell Model

    International Journal of Molecular Sciences, Vol. 24, Núm. 7

  2. Corrigendum to: Prophylactic use of incisional negative pressure wound therapy for the prevention of surgical site occurrences in general surgery: Consensus document: [Surgery 173/4 (April 2023) 1052– 1059/7908](S0039606022010121)(10.1016/j.surg.2022.11.033)

    Surgery (United States)

  3. Prophylactic use of incisional negative pressure wound therapy for the prevention of surgical site occurrences in general surgery: Consensus document

    Surgery (United States), Vol. 173, Núm. 4, pp. 1052-1059

  4. The pathophysiological impact of intra-abdominal hypertension in pigs

    PLoS ONE, Vol. 18, Núm. 8 August

2022

  1. Caso clínico de micetoma por actinomadura en adolescente con patología crónica compleja

    Heridas y cicatrización: Revista de la Sociedad Española de Heridas, Vol. 12, Núm. 1, pp. 108-108

2021

  1. Efficacy and safety of intramuscular administration of allogeneic adipose tissue derived and expanded mesenchymal stromal cells in diabetic patients with critical limb ischemia with no possibility of revascularization: study protocol for a randomized controlled double-blind phase II clinical trial (The NOMA Trial)

    Trials, Vol. 22, Núm. 1

2020

  1. Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus (Frontiers in Immunology, (2019), 10, 10.3389/fimmu.2019.01151)

    Frontiers in Immunology

  2. Terapia celular con membrana amniótica para la epitelización de úlceras complejas de pie diabético

    Enfermería Dermatológica, Año 14, Núm. 39, pp. 36-43

2019

  1. Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus

    Frontiers in Immunology, Vol. 10, Núm. JUN

2018

  1. Amniotic membrane stimulates cell migration by modulating transforming growth factor-β signalling

    Journal of Tissue Engineering and Regenerative Medicine, Vol. 12, Núm. 3, pp. 808-820

  2. Cryopreserved amniotic membrane in the treatment of diabetic foot ulcers: A case series

    Journal of Wound Care, Vol. 27, Núm. 12, pp. 806-815

  3. Intestinal histopathological changes in a porcine model of pneumoperitoneum-induced intra-abdominal hypertension

    Surgical Endoscopy, Vol. 32, Núm. 9, pp. 3989-4002

  4. Necrosis pancreática infectada: absceso de páncreas

    Los síndromes infecciosos a través de la clínica (Servicio de Publicaciones), pp. 159-167

  5. Time-course evaluation of intestinal structural disorders in a porcine model of intraabdominal hypertension by mechanical intestinal obstruction

    PLoS ONE, Vol. 13, Núm. 1

2017

  1. Amniotic membrane application for the healing of chronic wounds and ulcers

    Placenta, Vol. 59, pp. 146-153